市場調査レポート

商品コード

1509828

米国の造影剤と放射性医薬品市場：Medtech 360

Contrast Agents and Radiopharmaceuticals | Medtech 360 | Market Insights | United States

出版日: 2024年06月25日
発行: Clarivate
ページ情報: 英文
納期: 即日から翌営業日

価格

全表示
概要
目次

概要

サンプル依頼リストに入れる

米国の造影剤と放射性医薬品市場は、予測期間を通じて緩やかな成長が見込まれます。市場成長の原動力となるのは、PETとMRIの検査件数の増加、CEUSとPET検査における造影剤の使用拡大です。しかし、特定のモダリティにおけるガドリニウムや放射線被曝に対する懸念が引き続き存在するため、市場はやや限定的となります。さらに、「価値観に基づく医療」へのシフトが特定の処置の障壁となり、代わりに最高レベルの精度と鮮明な可視化を提供する処置が支持されると考えられます。今後の市場発展の原動力となるのは、現在開発中または臨床試験中の新規造影剤の導入と、FDAによる既存造影剤の適応拡大承認となる見通しです。

当レポートでは、米国の造影剤と放射性医薬品の市場に関する包括的なデータと分析 (2019年～2033年) を提供しております。

PSMA PETイメージング薬剤のFDA承認件数は徐々に増加しています。

どのPETイメージング薬剤がFDAの承認を受けているのか？
これらのPSMA PETイメージング薬剤にはどのような利点があるのか？
どのような適応症で承認されているか？

メーカーは造影剤製品の臨床評価に積極的に取り組んでいます。

臨床評価中の造影剤にはどのようなものがあるか？
既存の造影剤と比較して、どのような利点があるのか？

FDAは放射線治療におけるCEUSの使用承認を拡大しました。

この承認はどのような処置に適用されるのか？将来、どのような処置が追加承認される可能性があるか？
どの造影剤がFDAの承認を受けているのか？
これらのFDA承認は、競合情勢をどのように変えるのか？

ガドリニウム滞留の影響に関する懸念が、造影式MRIの使用に悪影響を及ぼすと思われます。

ACO・医療ネットワーク・医師はガドリニウム滞留に関する最近の見解にどのように対応しているか？
直鎖状GBCAと大環状GBCAの主な違いは何か？これらの製品に対する市場需要は今後どのように変化していくのか？
その他の画像モダリティは、造影式MRI処置の市場を蚕食するのか？
大環状GBCAへのシフトから恩恵を受ける企業（および関連製品）はどれか？

The US contrast agents and radiopharmaceutical market will see moderate growth over the forecast period. Market growth will be driven by rising PET and MRI procedure volumes, and the expanding use of imaging agents in CEUS and PET procedures. However, the market will be somewhat limited by the continued concern over gadolinium and radiation exposure in certain modalities. Additionally, the shift toward value-based care will act as a barrier for certain procedures, favoring those that offer the highest levels of accuracy and clarity in visualization instead. Moving forward, market growth will be driven by the introduction of new contrast agents currently in development or undergoing clinical trials, along with FDA approvals for expanded indications of existing contrast agents.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for contrast agents and radiopharmaceuticals in the US from 2019 through 2033.

There has been a gradual increase in the number FDA approvals for PSMA PET imaging agents.

Which PET imaging agents have received FDA approval?
What advantages do these PSMA PET imaging agents offer?
What indications are they approved for?

Manufacturers are actively engaging in ongoing clinical evaluation of their contrast agent products.

Which contrast agent products are under clinical evaluation?
What advantage do they offer over the existing contrast agents in the market.

The FDA expanded approval for the use of CEUS in radiology procedures.

What type of procedures does this approval extend to? What additional procedures could be approved in the future?
Which contrast agents have received FDA approval?
How will these FDA approvals change the competitive landscape.

Looming concerns over the effects of gadolinium retention will negatively affect the use of contrast-enhanced MRI.

How are ACOs, health networks, and physicians responding to the recent findings on gadolinium retention?
What are the key differences between linear and macrocyclic GBCAs, and how will market demand for these products shift going forward?
Will other imaging modalities cannibalize contrast-enhanced MRI procedures?
Which companies (and associated products) will benefit from the shift to macrocyclic GBCAs?

United States

Abstract

Executive Summary

COVID-19 Updates
Market Highlights
Competitive Highlights
Market Developments
Procedures and Products Covered

Key Report Updates

Contrast Agent and Radiopharmaceutical Market

Market Highlights
- Key Content Updates
Market Definitions
Market Forecast Data
Market Shares
Competitive Insights
- Cardinal Health
- GE Healthcare
- Bracco Group
- Lantheus Holdings
- Bayer Healthcare
- Other Key Competitors
- Factors Affecting All Competitors
Market Developments

Radiopharmaceutical Market

Market Highlights
- Key Content Updates
Market Definitions
Market Forecast Data
Market Shares
Competitive Insights
- US Radiopharmaceutical Market Competitive Insights

CT and X-Ray Contrast Agent Market

Market Highlights
- Key Content Updates
Market Definitions
Market Forecast Data
Market Shares
Competitive Insights
- US CT and X-Ray Contrast Agent Market Competitive Insights

MRI Contrast Agent Market

Market Highlights
- Key Content Updates
Market Definitions
Market Forecast Data
Market Shares
Competitive Insights
- US MRI Contrast Agent Market Competitive Insights
- Factors Affecting All Competitors

Ultrasound Contrast Agent Market

Market Highlights
- Key Content Updates
Market Definitions
Market Forecast Data
Market Shares
Competitive Insights
- US Ultrasound Contrast Agent Market Competitive Insights

Appendix

Abbreviations
Bibliography

Tables and Figures

Contrast Agent and Radiopharmaceutical Market, by Product Type, US (USD), 2019-2033
Contrast Agent and Radiopharmaceutical Market Landscape, US (USD), 2023 and 2033
Competitive Insights
Contrast Agent and Radiopharmaceutical Market Share Rankings, by Product Type, US, 2023
Companies Mentioned
Recent Events in the Contrast Agent and Radiopharmaceutical Market, US
Key Clinical Trials in the Contrast Agent and Radiopharmaceutical Market, US
Emerging Products for the Contrast Agent and Radiopharmaceutical Market, US
Contrast Agent and Radiopharmaceutical Procedures and Products Covered, US
US Contrast Agent and Radiopharmaceutical Market Drivers
US Contrast Agent and Radiopharmaceutical Market Limiters
Contrast Agent and Radiopharmaceutical Market, by Product Type, US (USD), 2019-2033
Contrast Agent and Radiopharmaceutical Procedures, by Product Type, US, 2019-2033
Contrast Agent and Radiopharmaceutical Market, by Product Type, US (USD), 2019-2033
Contrast Agent and Radiopharmaceutical Revenue Market Shares, US, 2023
Contrast Agent and Radiopharmaceutical Revenue Market Shares, by Product Type, US, 2023
Cardinal Health Competitive Insights
GE Healthcare Competitive Insights
Bracco Group Competitive Insights
Lantheus Holdings Competitive Insights
Bayer Healthcare Competitive Insights
Competitive Insights for Other Key Competitors
Recent Events in the Contrast Agent and Radiopharmaceutical Market, US
Key Clinical Trials in the Contrast Agent and Radiopharmaceutical Market, US
Emerging Products for the Contrast Agent and Radiopharmaceutical Market, US
US Radiopharmaceutical Market Drivers
US Radiopharmaceutical Market Limiters
Radiopharmaceutical Market, by Product Type, US (USD), 2019-2033
Radiopharmaceutical Market, by Product Type, US (USD), 2019-2033
Radiopharmaceutical Market Growth, by Product Type, US, 2020-2033
Nuclear Medicine System Installed Base, by Product Type, US, 2019-2033
Radiopharmaceutical Revenue Market Shares, US, 2023
Radiopharmaceutical Revenue Market Shares, by Product Type, US, 2023
US CT and X-Ray Contrast Agent Market Drivers
US CT and X-Ray Contrast Agent Market Limiters
CT and X-Ray Contrast Agent Market, by Product Type, US (USD), 2019-2033
CT and X-Ray Contrast Agent Market, by Product Type, US (USD), 2019-2033
CT and X-Ray Contrast Agent Market Growth, by Product Type, US, 2020-2033
CT and X-Ray System Installed Base, by Product Type, US, 2019-2033
CT Contrast Agent Market, by Procedure Type, US (USD), 2019-2033
CT Contrast Agent Market Growth, by Procedure Type, US, 2020-2033
X-Ray, Contrast Agent Market, by Procedure Type, US (USD), 2019-2033
CT and X-Ray Contrast Agent Revenue Market Shares, US, 2023
CT and X-Ray Contrast Agent Revenue Market Shares, US, 2023
US MRI Contrast Agent Market Drivers
US MRI Contrast Agent Market Limiters
MRI Contrast Agent Market, by Procedure Type, US (USD), 2019-2033
MRI Contrast Agent Market, by Procedure Type, US (USD), 2019-2033
MRI Contrast Agent Market Growth, by Procedure Type, US, 2020-2033
MRI System Installed Base, US, 2019-2033
MRI Contrast Agent Revenue Market Shares, US, 2023
MRI Contrast Agent Revenue Market Shares, US, 2023
US Ultrasound Contrast Agent Market Drivers
US Ultrasound Contrast Agent Market Limiters
Ultrasound Contrast Agent Market, US (USD), 2019-2033
Ultrasound Contrast Agent Market, US (USD), 2019-2033
Ultrasound Contrast Agent Revenue Market Shares, US, 2023
Ultrasound Contrast Agent Revenue Market Shares, US, 2023